Olon Spa, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is TRILACICLIB DIHYDROCHLORIDE, with a corresponding US DMF Number 40022.
Remarkably, this DMF maintains an Active status since its submission on June 20, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 09, 2024, and payment made on June 13, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II